Works matching IS 00778923 AND DT 2001 AND VI 949 AND IP 1
Results: 56
Preventing and Treating Osteoporosis.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 188, doi. 10.1111/j.1749-6632.2001.tb04020.x
- By:
- Publication type:
- Article
The Past, Present, and Future of Selective Estrogen Receptor Modulation.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 72, doi. 10.1111/j.1749-6632.2001.tb04004.x
- By:
- Publication type:
- Article
Developing Animal Models for Analyzing SERM Activity.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 36, doi. 10.1111/j.1749-6632.2001.tb04000.x
- By:
- Publication type:
- Article
Structure-Function Relationships in Estrogen Receptors and the Characterization of Novel Selective Estrogen Receptor Modulators with Unique Pharmacological Profiles.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 6, doi. 10.1111/j.1749-6632.2001.tb03998.x
- By:
- Publication type:
- Article
Tissue-Specific Estrogen Biosynthesis and Metabolism.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 58, doi. 10.1111/j.1749-6632.2001.tb04002.x
- By:
- Publication type:
- Article
FDA Review Practices and Priorities for Drugs Used in Cancer Treatment<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 341, doi. 10.1111/j.1749-6632.2001.tb04042.x
- By:
- Publication type:
- Article
Estrogen Receptor-active Compounds, Estrogens and SERMs, of Historical and Current Interest.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 381, doi. 10.1111/j.1749-6632.2001.tb04048.x
- Publication type:
- Article
Conclusions.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 352, doi. 10.1111/j.1749-6632.2001.tb04045.x
- By:
- Publication type:
- Article
Tamoxifen for the Reduction in the Incidence of Breast Cancer in Women at High Risk for Breast Cancer<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 345, doi. 10.1111/j.1749-6632.2001.tb04043.x
- By:
- Publication type:
- Article
SERMs, Estrogen, and Cognitive Function.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 202, doi. 10.1111/j.1749-6632.2001.tb04022.x
- By:
- Publication type:
- Article
The Breast Cancer Continuum.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 327, doi. 10.1111/j.1749-6632.2001.tb04040.x
- By:
- Publication type:
- Article
Reproductive and Related Endocrine Considerations.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 235, doi. 10.1111/j.1749-6632.2001.tb04026.x
- By:
- Publication type:
- Article
Negotiating Industry-Sponsored Clinical Trial Agreements.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 349, doi. 10.1111/j.1749-6632.2001.tb04044.x
- By:
- Publication type:
- Article
The Estimation and Use of Absolute Risk for Weighing the Risks and Benefits of Selective Estrogen Receptor Modulators for Preventing Breast Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 286, doi. 10.1111/j.1749-6632.2001.tb04034.x
- By:
- Publication type:
- Article
Quality of Life and Tamoxifen in a Breast Cancer Prevention Trial.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 143, doi. 10.1111/j.1749-6632.2001.tb04012.x
- By:
- Publication type:
- Article
Weighing the Benefits and Risks in Clinical Trials and Practice.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 279, doi. 10.1111/j.1749-6632.2001.tb04032.x
- By:
- Publication type:
- Article
The Paradox of Small Changes in Bone Density and Reductions in Risk of Fracture with Raloxifene.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 198, doi. 10.1111/j.1749-6632.2001.tb04021.x
- By:
- Publication type:
- Article
The Basic Biology of SERMs.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 1, doi. 10.1111/j.1749-6632.2001.tb03996.x
- By:
- Publication type:
- Article
Cancer Treatment and Prevention.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 68, doi. 10.1111/j.1749-6632.2001.tb04003.x
- By:
- Publication type:
- Article
The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 333, doi. 10.1111/j.1749-6632.2001.tb04041.x
- By:
- Publication type:
- Article
Defining Benefits and Risks for SERMs in Clinical Trials and Clinical Practice.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 304, doi. 10.1111/j.1749-6632.2001.tb04037.x
- By:
- Publication type:
- Article
Roles of Industry, Government, and Academia in SERM Development.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 315, doi. 10.1111/j.1749-6632.2001.tb04038.x
- By:
- Publication type:
- Article
Opportunities for Future Research.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 366, doi. 10.1111/j.1749-6632.2001.tb04046.x
- By:
- Publication type:
- Article
SERMs, Ethnicity, and Clinical Trials.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 292, doi. 10.1111/j.1749-6632.2001.tb04035.x
- By:
- Publication type:
- Article
Estrogen Replacement Therapy for the Potential Treatment or Prevention of Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 223, doi. 10.1111/j.1749-6632.2001.tb04025.x
- By:
- Publication type:
- Article
Timeline of Key Events in SERM Development.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 377, doi. 10.1111/j.1749-6632.2001.tb04047.x
- Publication type:
- Article
The Italian Breast Cancer Prevention Trial with Tamoxifen.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 113, doi. 10.1111/j.1749-6632.2001.tb04009.x
- By:
- Publication type:
- Article
Cardiovascular Trials of Estrogen Replacement Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 153, doi. 10.1111/j.1749-6632.2001.tb04014.x
- By:
- Publication type:
- Article
Effects of Estrogen and Selective Estrogen Receptor Modulators on Hemostasis and Inflammation.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 175, doi. 10.1111/j.1749-6632.2001.tb04017.x
- By:
- Publication type:
- Article
Prevention and Treatment of Osteoporosis.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 186, doi. 10.1111/j.1749-6632.2001.tb04019.x
- By:
- Publication type:
- Article
Selective Estrogen Receptor Modulator Effects on Serum Lipoproteins and Vascular Function in Postmenopausal Women and in Hypercholesterolemic Men.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 168, doi. 10.1111/j.1749-6632.2001.tb04016.x
- By:
- Publication type:
- Article
Capitalizing on the Complexities of Estrogen Receptor Pharmacology in the Quest for the Perfect SERM.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 16, doi. 10.1111/j.1749-6632.2001.tb03999.x
- By:
- Publication type:
- Article
Breast Cancer Prevention with Selective Estrogen Receptor Modulators.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 89, doi. 10.1111/j.1749-6632.2001.tb04006.x
- By:
- Publication type:
- Article
Action of SERMs in Target Tissues.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 383, doi. 10.1111/j.1749-6632.2001.tb04050.x
- Publication type:
- Article
Benefit/Risk Assessment of SERM Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 280, doi. 10.1111/j.1749-6632.2001.tb04033.x
- By:
- Publication type:
- Article
The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic-Pituitary-Gonadal Axis.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 251, doi. 10.1111/j.1749-6632.2001.tb04029.x
- By:
- Publication type:
- Article
Estrogens, Selective Estrogen Receptor Modulators, and Dementia: What Is the Evidence?
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 215, doi. 10.1111/j.1749-6632.2001.tb04024.x
- By:
- Publication type:
- Article
Rationale and Overview of the Raloxifene Use for the Heart (RUTH) Trial.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 181, doi. 10.1111/j.1749-6632.2001.tb04018.x
- By:
- Publication type:
- Article
Raloxifene: Risks and Benefits.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 295, doi. 10.1111/j.1749-6632.2001.tb04036.x
- By:
- Publication type:
- Article
A Brief Review of the International Breast Cancer Intervention Study (IBIS), the Other Current Breast Cancer Prevention Trials, and Proposals for Future Trials<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 123, doi. 10.1111/j.1749-6632.2001.tb04010.x
- By:
- Publication type:
- Article
The Effect of SERMs on the Endometrium.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 237, doi. 10.1111/j.1749-6632.2001.tb04027.x
- By:
- Publication type:
- Article
The Effects of Estrogen and Selective Estrogen Receptor Modulators on Cardiovascular Risk Factors.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 163, doi. 10.1111/j.1749-6632.2001.tb04015.x
- By:
- Publication type:
- Article
The MORE Trial: Multiple Outcomes for Raloxifene Evaluation.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 134, doi. 10.1111/j.1749-6632.2001.tb04011.x
- By:
- Publication type:
- Article
Translation of Basic Research: Finding the Perfect SERM.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 259, doi. 10.1111/j.1749-6632.2001.tb04030.x
- By:
- Publication type:
- Article
Use of SERMs for the Adjuvant Therapy of Early-Stage Breast Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 80, doi. 10.1111/j.1749-6632.2001.tb04005.x
- By:
- Publication type:
- Article
The Royal Marsden Hospital (RMH) Trial.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 109, doi. 10.1111/j.1749-6632.2001.tb04008.x
- By:
- Publication type:
- Article
Nuclear Receptors, Coregulators, Ligands, and Selective Receptor Modulators.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 3, doi. 10.1111/j.1749-6632.2001.tb03997.x
- By:
- Publication type:
- Article
Androgen Receptor: Structural Domains and Functional Dynamics after Ligand-Receptor Interaction.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 44, doi. 10.1111/j.1749-6632.2001.tb04001.x
- By:
- Publication type:
- Article
The Role of Tamoxifen in Breast Cancer Prevention.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 99, doi. 10.1111/j.1749-6632.2001.tb04007.x
- By:
- Publication type:
- Article
Model of Estrogen Receptor (ER) Action.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 949, n. 1, p. 382, doi. 10.1111/j.1749-6632.2001.tb04049.x
- Publication type:
- Article